|
CN110857292A
|
|
EGFR kinase inhibitor and preparation method and application thereof
|
|
CN110606842A
|
|
Process for producing pyridylamino pyrimidine derivative and intermediate thereof
|
|
CN110606841A
|
|
Crystal form of pyridylamino pyrimidine derivative and preparation method thereof
|
|
CN110272419A
|
|
Dihydro pyrido phthalazinone derivatives, preparation method and application
|
|
CN107459519A
|
|
Annelated pyrimidines piperidines ring derivatives and its preparation method and application
|
|
CN107163026A
|
|
Salt of pyridine amine pyrimidine derivates and its preparation method and application
|
|
CN110590749A
|
|
Crystal form of pyridylamino pyrimidine derivative mesylate, preparation and application thereof
|
|
CN106892929A
|
|
Spiroketals derivative and its preparation method and application
|
|
CN105315259A
|
|
Pyridylamino pyrimidine derivative, preparation method therefor and application of pyridylamino pyrimidine derivative
|
|
CN105218561A
|
|
Annelated pyrimidines ring derivatives, its preparation method and application
|
|
CN103965171A
|
|
Preparation method for Allisartan Isoproxil
|
|
CN104788365A
|
|
Isonicotinamide derivative, preparation method and applications thereof
|
|
CN103204844A
|
|
Amino heteroaryl compound, and preparation method and application thereof
|
|
CN102827286A
|
|
Fusion protein of Exendin-4 and mutational human serum albumin, and preparation method of fusion protein
|
|
CN102731525A
|
|
Benzomorpholine derivative
|
|
CN102584828A
|
|
Pyrrolidine[3,4-d]pyrimidine derivative and preparation method and application thereof
|
|
CN102453026A
|
|
C-aryl glucoside derivative, preparation method and application thereof
|
|
CN102268014B
|
|
Condensed heteroaryl derivative and its preparation method and use
|
|
CN102234286A
|
|
Condensed heteroaryl derivatives
|
|
CN102146059A
|
|
Quinazoline derivatives and preparation method and application thereof
|
